Journal List > Yonsei Med J > v.60(7) > 1128165

Lee, Seo, Chu, Kim, Jang, Jeong, Yum, Han, Yoon, Cho, Rha, Kim, Park, Seo, Lee, and Park: Current Status of Patient Education in the Management of Atopic Dermatitis in Korea

Abstract

Patient education is important for successful management of atopic dermatitis; however, due to limited time and resources, patient education remains insufficient. This study aimed to investigate the current state of education provided by Korean dermatologists, pediatric allergists, and allergists to patients with atopic dermatitis. A questionnaire survey consisting of items regarding educational programs for patients with atopic dermatitis was conducted via e-mail. In total, 153 participants responded to the questionnaires, and 26.8% indicated that they have had separate educational programs. The workforce involved in the educational program included nurses, residents or fellows, dieticians, pharmacists, and clinical psychologists. Most education protocols addressed the characteristics and natural course of atopic dermatitis and environmental management. Overall, 96.7% of the participants replied that an additional charge is needed for education; moreover, additional assistance from an academic society or association, in the form of medical staff, organized data, and advertisement, is required to develop and provide a well-structured educational program. A standardized education protocol will effectively provide appropriate education for patients with atopic dermatitis. Arrangement of education fees, covered by the National Health Insurance Service, will lead to the establishment of a structured educational program and participation of an additional medical workforce.

Atopic dermatitis (AD) is a chronic dermatological condition with increasing prevalence, which is becoming a major social issue.1 Since the disease poses great economic burden and has a negative impact on the patient's daily life,2 long-term national treatment plans should be considered.3
A deluge of scientifically unconfirmed information from the media and alternative medicine can cause patient to misunderstand AD.45 Moreover, fear of medical therapy may also lead to inappropriate treatment.6 Therefore, providing proper education to patients and their caregivers is important in improving the patient's attitude toward the disease, which may ensure better treatment compliance, and eventually the overall treatment response.78910
Although previous studies in Korea have demonstrated the need for education on AD,11 no study has assessed how the educational programs are provided. In this study, we administered a questionnaire to clinicians who currently treat patients with AD in Korea. Through this study, we aimed to assess the education status on AD and utilize the results as a foundation for the future development of a standardized educational program in Korea.
A survey was conducted between June and September 2017 via email to all clinicians registered with the Korean Dermatological Association (KDA); Korean Academy of Pediatric Allergy and Respiratory Disease (KAPARD); and Korean Academy of Asthma, Allergy, and Clinical Immunology (KAAACI), employed at various centers. This study was approved by the Institutional Review Board of Severance Hospital (IRB no. 4-2018-1018).
The questionnaire comprised of 22 questions, largely categorized under the following topics: 1) workplace; 2) presence of an educational program; 3) methodology used for the programs; and 4) necessary conditions for the implementation of programs.
The survey was sent via e-mail to 3420 clinicians, and 153 of them (44 dermatologists and 109 pediatric allergists or allergists) responded (Table 1). The average clinical experience duration was 17.88 years. Forty-eight participants (31.4%) were from primary private clinics, 22 (14.4%) were from secondary medical centers, and 82 (53.6%) were from tertiary centers (university hospitals). Clinicians reported the following consultation times: 14 participants (9.2%), ≤5 min; 56 participants (36.6%), 6–10 min; 55 participants (35.9%), 11–20 min; and 28 participants (18.3%), 21–30 min. No clinician spent longer than 30 min per patient. When asked about the ideal duration for education, among the 90 participants who responded, 43 participants (47.8%) indicated 15–30 min and 24 (26.7%) indicated 30–60 min to be preferable. Several responded that ≤15 min or ≥60 min would be needed [21/90 (23.3%) and 2/90 (2.2%), respectively].
We then assessed if any additional educational programs were provided. Among the 153 participants, 41 (26.8%) said a separate program was provided. Most of these responders were from university hospitals (30 participants), followed by secondary medical centers (seven participants), private clinics (three participants), and children's hospitals (two participants). Regarding the program, 33 of 41 participating clinicians (80.5%) provided an individual-level educational program, and four (9.7%) provided a group-level program. The remaining participants (9.7%) provided both individual- and group-level programs (Table 2).
We asked a different set of questions to the 37 clinicians who provided individual-level educational programs. Education was most often provided at the outpatient clinic (73%), whereas in some cases, a separate consultation room was used (27.6%). In very few cases, either a treatment room or a special information center was used. Group-level programs were offered at various venues, including an outpatient clinic, consultation room, hospital auditorium, and patient ward (Table 2). Among the workforce involved in individual-level programs (multiple answers allowed), nurses were found to be most frequently involved (23 participants), followed by residents or fellows (19), dieticians (five), pharmacists (two), and clinical psychologists (one). Similar results were found for group-level programs.
We then assessed the frequency of education (Fig. 1). For the centers that provided an individual-level program, 23 of 37 centers (62.2%) provided the program only at the time of initial diagnosis, and nine centers (24.3%) provided the program during every consultation. While some (13.5%) provided education one to three times annually, no center provided education more than four times a year. Regarding group-level education, among the eight centers, five (62.5%) provided education ≤six times per year; two centers, more than seven times per year; and one center provided education as needed. Individual- and group-level educational programs were provided for both the patients and their caregivers in 97.3% and 100% of the centers, respectively. In most cases (97.6%), no extra costs were charged for additional education.
The survey also inquired about the topics covered. Details are shown in Fig. 2. Regarding the natural course of the disease, all centers addressed its chronicity. Among the 41 responders, 38 (92.7%) reported that the education included disease characteristics of each age group, and 36 (87.8%) reported that the associations with other allergic diseases were also included. For daily skin care, more than 92.7% of the responders said they covered topics such as lukewarm baths, moisturizer use, and coping with the urge to scratch.
Regarding the use of medications, 31 of 41 (75.6%) responders stated that proper application of topical ointments was shown through demonstration. Similarly, 24 responders (58.5%) stated that education covered wet-wrap therapy, in which 41.7% were pediatricians/allergists and 58.3% were dermatologists. Of the 41 participants, 36 (87.8%) responded that they covered proper ointment use upon symptomatic exacerbations. These indicate a relatively lower rate of detailed instructions on medication use. For the management of environmental and aggravating factors, 39 (95.1%) responders stated that the programs covered temperature and humidity management, 34 (83%) reported the benefits of wearing cotton-based clothing, and 35 (85.4%) reported the control of exposure to common allergens.
Regarding diet, only 20 responders (48.8%) said they had surveyed patients' diets. Thirty-seven (90.2%) indicated that they advised elimination of food that exacerbate symptoms, and 29 (70.7%) said the programs included education on alternative foods. Most responders (92.7%) advised against unwarranted dietary restrictions. In terms of nutritional counseling, in contrast to 27.3% of dermatologists, 73.3% of allergists said they understood the patients' nutritional status. Meanwhile, only nine (22%) provided psychologic counseling.
We also assessed the sources of data used for the programs, and multiple answers were allowed. Thirty-three (80.5%) responders stated that they developed their own educational materials. Eighteen participants utilized materials from academic societies or associations. Oral presentation was the main delivery method (35 participants), followed by handouts (32 participants) and video-based information (11 participants). Four participants used other methods, including information panels, tools, and presentation slides. Objective indices, such as Eczema Area Severity Index (EASI) and SCORing Atopic Dermatitis (SCORAD), were used by 41.5% of the responders.
For 109 participants who did not provide the educational program, 58 out of 90 participants (64.4%) preferred individual-level education, whereas only 10 participants (11.1%) preferred group-level education. The remaining 24.4% of the participants indicated that both educational programs were required.
Overall, 96.7% of the participants said an additional charge was needed for education on AD. Furthermore, they mentioned that additional assistance from an academic society or association, in the form of medical staff, organized data, and advertisement, was required to provide a well-structured educational program. Eighty-seven out of 90 participants (96.7%) were willing to provide education for patients with AD if an appropriate consultation fee was provided. Therefore, with an additional budget for education on AD, more patients will surely benefit.
According to the results, only 26.8% of the centers scheduled additional time aside from the clinics to provide an appropriate education. Most of them were university hospitals, likely due to the smaller number of clinicians from private clinics in this study and greater academic interest in patient education in university hospitals. Most participants provided individual-level education, held mostly at an outpatient clinic. There was only one case where a dedicated venue for patient education was available, reflecting the scarcity of appropriate venues. Nurses primarily comprised most of the workforce involved in the programs.
Even if a separate education was provided, it was usually performed only at the initial visit. Similarly, for group-level education, most centers provided only six sessions or less per year. The appropriate management of chronic conditions requires continuous and repetitive patient education.1213 However, education was not up to these standards in real clinical settings. Furthermore, more than one-third of the respondents reported that the average consultation time for each patient was 5–10 min, and no one spent longer than 30 min per patient. Meanwhile, the majority indicated that education should last for longer than 15 min, some even suggesting that education should be 30 min or longer. Therefore, although clinicians realize the need for additional time for education, it may be difficult to achieve under the current circumstances.
Regarding the education method, oral communication and handouts were most commonly utilized. Indeed, audio-visual materials can significantly improve patient understanding,1415 but most centers used self-developed handouts. Therefore, a unified and reliable educational material must be developed.
The educational programs sought to thoroughly explain various aspects of the disease and its management. However, not many programs included information on the application of ointment, diet, or psychological aspects. Daily skin care is important, and direct or video demonstration would be more effective in providing adequate education for bathing and skin care.16 It is well-known that topical therapy is fundamental; however, it should be adjusted according to the patient's conditions. Furthermore, due to the lack of understanding among caregivers, most of them seek dietary therapy to cope with AD. A survey-based study17 showed that about 43% of the responders indicated dietary management to be most important, and more than half of the patients previously had tried dietary restriction. Dietary restrictions must be made only with confirmed food allergy,18 and when needed, education on alternative nutrition is important to prevent malnutrition. Therefore, dieticians must also be involved in the education.19
The deleterious effect of psychological stress in AD has been well-recognized. AD results in social intimidation and reduced quality of life.2021 Furthermore, psychological comorbidities, including anxiety and depression, are more prevalent in patients with AD.22 Stress then worsens the condition, leading to a vicious cycle. Also, psychological intervention and behavioral therapy against itch and scratching have been reported to improve the condition.2324 In summary, treatment of AD needs to be supported by an educational program consisting of a team of different professionals, including dermatologists, pediatric allergists, nurses, psychological clinicians, and dieticians, and should endeavor towards a multidisciplinary approach.25
Most of the clinicians who participated in this study asserted a need for an additional consultation fee for the education of AD, as a more proper type of education can be provided after the arrangement. Several issues, including limited time and inadequate medical staff, reportedly prevented clinicians from actively providing appropriate education in Korea. Through recognition of such needs, an appropriate consultation fee has already been adjusted for several chronic diseases, including diabetes, asthma, and cardiovascular disease, in Korea. Since AD is also a chronic disease with high prevalence, patients with AD would surely benefit from the education.26
In Korea, five different municipal governments have established educational and informational centers for AD and asthma. However, additional manpower and time are needed to properly carry out the programs, and a more tailored protocol according to the patient's age or severity is required.272829 As the importance of education in AD is emphasized, structured educational programs are being provided globally, especially in Europe and the United States, which are supported and funded by various organizations.3031 Likewise, the arrangement of education fees will lead to the establishment of a structured educational program with additional medical staff in Korea.
Due to the small sample size, low response rate, and possible selection bias associated with the survey, the results do not fully represent all clinicians who manage patients with AD. Therefore, a multi-center study involving a larger number of clinicians should be performed in the future. We hope that our data will be used as baseline data for the future development of standardized education and consultation protocol for patients with AD.

Figures and Tables

Fig. 1

Frequency of (A) individual- and (B) group-level education.

ymj-60-694-g001
Fig. 2

Detailed educational contents included in the programs.

ymj-60-694-g002
Table 1

Characteristics of Participants

ymj-60-694-i001

Values are presented as n (%).

Table 2

Responses Regarding Individual and Group Education

ymj-60-694-i002

Values are presented as n (%).

*Multiple answers were allowed; Others include center (treatment room) for atopic dermatitis and asthma for individual-level education, as well as hospital auditorium and patient ward for group-level education; Others include cases wherein the clinician, primary investigator, or specialized nurses provided the education.

ACKNOWLEDGEMENTS

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Scienceand ICT) (No. NRF-2017R1A2B4009568).

Notes

The authors have no potential conflicts of interest to disclose.

AUTHOR CONTRIBUTIONS

  • Conceptualization: Man Yong Han, Yeong Ho Rha, and Chang Ook Park.

  • Data curation: Ju-Hee Seo and Yong Hyun Jang.

  • Formal analysis: Min Kyung Lee and Jae Won Jeong.

  • Funding acquisition: Chang Ook Park.

  • Investigation: Hyunjung Kim and Yeong Ho Rha.

  • Methodology: Hyunjung Kim and Hye Yung Yum.

  • Project administration: Man Yong Han and Chang Ook Park.

  • Resources: Man Yong Han and Chang Ook Park.

  • Software: Min Kyung Lee and Ju-Hee Seo.

  • Supervision: Man Yong Han, Sang-Heon Cho, Jin-Tack Kim, Young Lip Park, Seong Jun Seo, Kwang Hoon Lee, and Chang Ook Park.

  • Validation: Yong Hyung Jang and Hye Yung Yum.

  • Visualization: Ho Joo Yoon and Jin-Tack Kim.

  • Writing—original draft: Min Kyung Lee and Howard Chu.

  • Writing—review & editing: Ju-Hee Seo, Howard Chu, and Chang Ook Park.

References

1. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am. 2010; 30:269–280.
crossref
2. Morren MA, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol. 1994; 31(3 Pt 1):467–473.
crossref
3. Kim JE, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH, et al. Consensus guidelines for the treatment of atopic dermatitis in Korea (Part I): general management and topical treatment. Ann Dermatol. 2015; 27:563–577.
crossref
4. Chin HW, Jang HS, Jang BS, Jo JH, Kim MB, Oh CK, et al. A study on utilization of alternative medicine for patients with atopic dermatitis. Korean J Dermatol. 2005; 43:903–911.
5. Kim JK, Kim JH, Lim DH, Son BK. Qualitative assessment of atopic dermatitis-related websites. Pediatr Allergy Respir Dis. 2007; 17:282–288.
6. Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol. 2017; 153:1036–1042.
7. Shin JY, Kim DW, Park CW, Seo SJ, Park YL, Lee JR, et al. An educational program that contributes to improved patient and parental understanding of atopic dermatitis. Ann Dermatol. 2014; 26:66–72.
crossref
8. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014; 71:1218–1233.
9. Pustišek N, Šitum M, Vurnek Živković M, Ljubojević Hadžavdić S, Vurnek M, Niseteo T. The significance of structured parental educational intervention on childhood atopic dermatitis: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2016; 30:806–812.
crossref
10. Jang YH, Lee JS, Kim SL, Song CH, Jung HD, Shin DH, et al. A family-engaged educational program for atopic dermatitis: a seven-year, multicenter experience in Daegu-Gyeongbuk, South Korea. Ann Dermatol. 2015; 27:383–388.
crossref
11. Yum HY, Han KO, Park J, Kang MY, Chang SI, Cho SH, et al. Improvement in disease knowledge through an education program of atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2012; 32:21–25.
12. Heratizadeh A, Werfel T, Wollenberg A, Abraham S, Plank-Habibi S, Schnopp C, et al. Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J Allergy Clin Immunol. 2017; 140:845–853.
crossref
13. Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006; 332:933–938.
crossref
14. Barbarot S, Gagnayre R, Bernier C, Chavigny JM, Chiaverini C, Lacour JP, et al. [A guide for education programs in atopic dermatitis]. Ann Dermatol Venereol. 2007; 134:121–127.
15. Agner T. Compliance among patients with atopic eczema. Acta Derm Venereol Suppl (Stockh). 2005; (215):33–35.
16. Niebel G, Kallweit C, Lange I, Fölster-Holst R. [Direct versus video-aided parent education in atopic eczema in childhood as a supplement to specialty physician treatment. A controlled pilot study]. Hautarzt. 2000; 51:401–411.
17. Lee JB, Rha YH, Choi SH. A questionnaire survey of care-givers' understanding of atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2009; 29:179–185.
18. Muraro A, Halken S, Arshad SH, Beyer K, Dubois AE, Du Toit G, et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy. 2014; 69:590–601.
crossref
19. Nicol NH, Ersser SJ. The role of the nurse educator in managing atopic dermatitis. Immunol Allergy Clin North Am. 2010; 30:369–383.
crossref
20. Chung SW, Chang EY, Lee HC, Shin MY, Kim BE, Ahn KM, et al. The relationships among severity score, behavioral problem, parental stress, maternal depression, and social support in children with atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2005; 25:39–44.
21. Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol. 1996; 7:149–154.
crossref
22. Senra MS, Wollenberg A. Psychodermatological aspects of atopic dermatitis. Br J Dermatol. 2014; 170:Suppl 1. 38–43.
crossref
23. Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995; 63:624–635.
crossref
24. Norén P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol. 1989; 121:359–366.
crossref
25. Boguniewicz M, Nicol N, Kelsay K, Leung DY. A multidisciplinary approach to evaluation and treatment of atopic dermatitis. Semin Cutan Med Surg. 2008; 27:115–127.
crossref
26. de Bes J, Legierse CM, Prinsen CA, de Korte J. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol. 2011; 91:12–17.
crossref
27. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol. 2012; 26:1176–1193.
crossref
28. Lim MS, Lee CH, Sim S, Hong SK, Choi HG. Physical activity, sedentary habits, sleep, and obesity are associated with asthma, allergic rhinitis, and atopic dermatitis in Korean Adolescents. Yonsei Med J. 2017; 58:1040–1046.
crossref
29. Lee J, Lee H, Noh S, Bae BG, Shin JU, Park CO, et al. Retrospective analysis on the effects of house dust mite specific immunotherapy for more than 3 years in atopic dermatitis. Yonsei Med J. 2016; 57:393–398.
crossref
30. Sy W, Lamb AJ. Atopic dermatitis disease education. Adv Exp Med Biol. 2017; 1027:179–184.
crossref
31. Stalder JF, Bernier C, Ball A, De Raeve L, Gieler U, Deleuran M, et al. Therapeutic patient education in atopic dermatitis: worldwide experiences. Pediatr Dermatol. 2013; 30:329–334.
crossref
TOOLS
ORCID iDs

Min Kyung Lee
https://orcid.org/0000-0001-7622-3276

Ju-Hee Seo
https://orcid.org/0000-0001-6783-2942

Howard Chu
https://orcid.org/0000-0001-5061-5351

Hyunjung Kim
https://orcid.org/0000-0001-5125-667X

Yong Hyun Jang
https://orcid.org/0000-0003-1706-007X

Jae Won Jeong
https://orcid.org/0000-0001-5340-1957

Hye Yung Yum
https://orcid.org/0000-0002-3997-4094

Man Yong Han
https://orcid.org/0000-0002-9077-5779

Ho Joo Yoon
https://orcid.org/0000-0002-4645-4863

Sang-Heon Cho
https://orcid.org/0000-0002-7644-6469

Yeong Ho Rha
https://orcid.org/0000-0001-5593-5020

Jin-Tack Kim
https://orcid.org/0000-0001-6903-0142

Young Lip Park
https://orcid.org/0000-0002-6532-3156

Seong Jun Seo
https://orcid.org/0000-0003-2915-839X

Kwang Hoon Lee
https://orcid.org/0000-0002-4361-1819

Chang Ook Park
https://orcid.org/0000-0003-3856-1201

Similar articles